Olaparib as the first-line maintenance therapy in advanced-stage epithelial ovarian cancer patients with BRCA mutations – Real-world experience from Taiwan
- DOI
- 10.1016/j.tjog.2025.01.016
- Published
- 2026-09
- Container
- Taiwanese Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.tjog.2025.01.016,
title = {Olaparib as the first-line maintenance therapy in advanced-stage epithelial ovarian cancer patients with BRCA mutations – Real-world experience from Taiwan},
author = {Wei-Jiun Tang and Shu-Han Chang and Chen-Bin Chang and Wei-Chun Chen and You-Chen Wang and Min-Yu Chen and Hung-Hsueh Chou},
year = {2026},
journal = {Taiwanese Journal of Obstetrics and Gynecology},
doi = {10.1016/j.tjog.2025.01.016},
url = {https://doi.org/10.1016/j.tjog.2025.01.016}
}RIS
TY - JOUR TI - Olaparib as the first-line maintenance therapy in advanced-stage epithelial ovarian cancer patients with BRCA mutations – Real-world experience from Taiwan AU - Wei-Jiun Tang AU - Shu-Han Chang AU - Chen-Bin Chang AU - Wei-Chun Chen AU - You-Chen Wang AU - Min-Yu Chen AU - Hung-Hsueh Chou PY - 2026 JO - Taiwanese Journal of Obstetrics and Gynecology DO - 10.1016/j.tjog.2025.01.016 UR - https://doi.org/10.1016/j.tjog.2025.01.016 ER -
APA
Tang, W., Chang, S., Chang, C., Chen, W., Wang, Y., Chen, M., & Chou, H. (2026). Olaparib as the first-line maintenance therapy in advanced-stage epithelial ovarian cancer patients with BRCA mutations – Real-world experience from Taiwan. Taiwanese Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.tjog.2025.01.016
Source records
- crossref · retrieved 2026-09-27T12:23:27.900Z